Washington University School of Medicine: Precursor Cell Lymphoblastic Leukemia-Lymphoma trials

The registry lists 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma studies with Washington University School of Medicine as lead sponsor. 2 are open to participants now and 5 have results posted.

Early Phase 1 1Phase 1 7Phase 2 4No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Weight Gain in Pediatric Leukemia SurvivorsNot yet recruitingNCT07374315Not applicable
• Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) PatientsRecruitingNCT07313592
• Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell TransplantationCompletedNCT03755414Phase 1Results posted
• BL-8040 and Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic LymphomaTerminatedNCT02763384Phase 2Results posted
• Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological MalignanciesCompletedNCT02639559Phase 2Results posted
• Azacitidine in Patients Undergoing Matched Unrelated Stem Cell TransplantationTerminatedNCT01747499Phase 1/2Results posted
• Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological MalignanciesCompletedNCT00241358Phase 1/2Results posted
• Family-Based Behavioral Treatment for Childhood Survivors of Acute Lymphoblastic LeukemiaTerminatedNCT05410574Not applicable
• Duvelisib Following Chimeric Antigen Receptor T-Cell TherapyActive, not recruitingNCT05044039Phase 1
• Azacitidine in Haploidentical Donor Hematopoietic Cell TransplantationTerminatedNCT02750254Phase 1
• Brentuximab Vedotin Prevention of (GVHD) After Unrelated Allogeneic Stem Cell TransplantationCompletedNCT01700751Phase 1
• Disrupting the Bone Marrow Microenvironment With G-CSF in Acute Lymphoblastic LeukemiaCompletedNCT01331590Early Phase 1
• Carfilzomib in Patients With Relapsed Acute Myeloid or Acute Lymphoblastic LeukemiaCompletedNCT01137747Phase 1